Building a World-Class Cannabis Hub

Aqualitas is committed to advancing cannabis science and consumer product development. We are developing Sindica – Global Institute for Cannabis Research and Innovation to act as an incubator for collaborative research and product development.

We are involved in ongoing research projects around cultivation practices, nutrient development, the development of beverages and edibles and have a US FDA Clinical Trial in progress. We’re proud to benefit from partnerships with Springboard Atlantic, Atlantic Canadian universities and colleges, and numerous federal and provincial research grants and awards.





Medical & Patient Advisory Board

Keys to providing market and product knowledge

Led by Dr. David Tilley (Chair) and Nancy Stapleton (Vice-Chair), the advisory board includes family and specialized medical professionals, research scientists, a nurse, a pharmacist, social worker, dietician, patient advocates, veterans and patients.

Words from our team

“Aqualitas has sought advice and feedback from medical patients and healthcare practitioners since its inception. This commitment to really listening to the needs of these groups gives me, as a medical consumer, incredible confidence in the company.”

Nancy Stapleton, Vice Chair, Medical & Patient Advisory Board and Communications Manager